390 related articles for article (PubMed ID: 24702804)
1. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
[TBL] [Abstract][Full Text] [Related]
2. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
[TBL] [Abstract][Full Text] [Related]
3. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
4. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
[TBL] [Abstract][Full Text] [Related]
5. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R
Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950
[TBL] [Abstract][Full Text] [Related]
6. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
[TBL] [Abstract][Full Text] [Related]
7. D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75.
Du L; Zhao Y; Chen J; Yang L; Zheng Y; Tang Y; Shen X; Jiang H
Biochem Biophys Res Commun; 2008 Oct; 375(1):139-44. PubMed ID: 18691555
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication.
De Rijck J; Vandekerckhove L; Gijsbers R; Hombrouck A; Hendrix J; Vercammen J; Engelborghs Y; Christ F; Debyser Z
J Virol; 2006 Dec; 80(23):11498-509. PubMed ID: 16987986
[TBL] [Abstract][Full Text] [Related]
9. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
10. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75.
Zhang DW; Yan HL; Xu XS; Xu L; Yin ZH; Chang S; Luo H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):906-912. PubMed ID: 32228103
[TBL] [Abstract][Full Text] [Related]
11. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction.
Zhang FH; Debnath B; Xu ZL; Yang LM; Song LR; Zheng YT; Neamati N; Long YQ
Eur J Med Chem; 2017 Jan; 125():1051-1063. PubMed ID: 27810592
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
[TBL] [Abstract][Full Text] [Related]
15. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
Chen WM; Liu XY
Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
Panwar U; Singh SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
[TBL] [Abstract][Full Text] [Related]
17. Daphnane-type diterpene esters with cytotoxic and anti-HIV-1 activities from Daphne acutiloba Rehd.
Huang SZ; Zhang XJ; Li XY; Kong LM; Jiang HZ; Ma QY; Liu YQ; Hu JM; Zheng YT; Li Y; Zhou J; Zhao YX
Phytochemistry; 2012 Mar; 75():99-107. PubMed ID: 22196934
[TBL] [Abstract][Full Text] [Related]
18. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
19. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
Vranckx LS; Demeulemeester J; Saleh S; Boll A; Vansant G; Schrijvers R; Weydert C; Battivelli E; Verdin E; Cereseto A; Christ F; Gijsbers R; Debyser Z
EBioMedicine; 2016 Jun; 8():248-264. PubMed ID: 27428435
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
